Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INVI Invitro International -- Ignore unavailable to you. Want to Upgrade?

To: Richard Mazzarella who wrote (380)	5/8/1998 4:55:00 PM
From: campe	Read Replies (1) \| Respond to of 486

* News Out * Friday May 8, 4:18 pm Eastern Time Company Press Release InVitro International Retains National Market Systems Inc. for Corporate Public Relations and Public Relations Consulting IRVINE, Calif.--(BUSINESS WIRE)--May 8, 1998--InVitro International (Bulletin Board: INVI - news) Friday announced that it has retained the services of National Marketing Systems Inc. to create and provide InVitro International with current marketing and distribution strategies, as well as the handling of its public news releases. President and Chief Executive Officer, W. Richard Ulmer, Friday stated that he feels that National Marketing is another step in the right direction for InVitro International. ''It will keep us on the cutting edge of the different marketing strategies available for our products and services. National Marketing will also help to keep the public aware as well as our shareholders informed of future business dealings.'' InVitro International is a global organization that offers laboratory testing for products and services including protocol development, customized contract testing services and kit sales in support of product claims, product formulation or workplace safety. InVitro International has offices in the United States as well as distributors in Japan, Korea, Asia, Germany, Italy, Belgium, Spain, Portugal and France. For further information regarding InVitro International's products or services, contact Richard Ulmer at 800/2-InVitro or visit the World Wide Web site at invitrointl.com. NOTE: Certain information in this document includes ''forward- looking statements'' within the meaning of applicable securities laws. In addition, from time to time the company or its executive officers have made or may make forward-looking statements, orally or in writing, that involve substantial risks and uncertainties. Actual results could differ materially from those projected or suggested by any forward-looking statements as a result of a wide variety of factors and conditions, including but not limited to, the ability of the company to continue as a going concern, market acceptance of new products and technologies, economic, competitive, governmental and technological factors affecting the company's operations, markets, services and prices, significant disruptions caused by third parties' failures to address the Year 2000 issues, litigation costs, changes in the company's operations, unanticipated events and various other factors. The reader is specifically referred to disclosures contained in this document and in prior documents, publicly disseminated by the company. Contact: InVitro International, Irvine Richard Ulmer, 800/2-InVitro biz.yahoo.com